Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia - PubMed (original) (raw)

Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia

Beatriz Rosón et al. Arch Intern Med. 2004.

Abstract

Background: Early failure is a matter of great concern in the treatment of community-acquired pneumonia. However, information on its causes and risk factors is lacking.

Methods: Observational analysis of a prospective series of 1383 nonimmunosuppressed hospitalized adults with community-acquired pneumonia. Early failure was defined as lack of response or worsening of clinical or radiologic status at 48 to 72 hours requiring changes in antibiotic therapy or invasive procedures. Concordance of antimicrobial therapy was examined for cases with an etiologic diagnosis.

Results: At 48 to 72 hours, 238 patients (18%) remained febrile, but most of them responded without further changes in antibiotic therapy. Eighty-one patients (6%) had early failure. The main causes of early failure were progressive pneumonia (n = 54), pleural empyema (n = 18), lack of response (n = 13), and uncontrolled sepsis (n = 9). Independent factors associated with early failure were older age (>65 years) (odds ratio [OR], 0.35), multilobar pneumonia (OR, 1.81), Pneumonia Severity Index score greater than 90 (OR, 2.75), Legionella pneumonia (OR, 2.71), gram-negative pneumonia (OR, 4.34), and discordant antimicrobial therapy (OR, 2.51). Compared with treatment responders, early failures had significantly higher rates of complications (58% vs 24%) and overall mortality (27% vs 4%) (P<.001 for both).

Conclusions: Early failure is infrequent but is associated with high morbidity and mortality rates. Its detection and management require careful clinical assessment. Most cases occur because of inadequate host-pathogen responses. Discordant therapy is a less frequent cause of failure, which may be preventable by rational application of the current antibiotic guidelines.

PubMed Disclaimer

Cited by

Novel biphasic role of LipoxinA(4) on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts.
Zheng S, Wang Q, He Q, Song X, Ye D, Gao F, Jin S, Lian Q. Zheng S, et al. Mediators Inflamm. 2011;2011:745340. doi: 10.1155/2011/745340. Epub 2011 Jul 2. Mediators Inflamm. 2011. PMID: 21765620 Free PMC article.
Comparative antibiotic failure rates in the treatment of community-acquired pneumonia: Results from a claims analysis.
Hess G, Hill JW, Raut MK, Fisher AC, Mody S, Schein JR, Chen CC. Hess G, et al. Adv Ther. 2010 Oct;27(10):743-55. doi: 10.1007/s12325-010-0062-1. Epub 2010 Aug 26. Adv Ther. 2010. PMID: 20799007 Free PMC article.
Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.
Cao B, Huang Y, She DY, Cheng QJ, Fan H, Tian XL, Xu JF, Zhang J, Chen Y, Shen N, Wang H, Jiang M, Zhang XY, Shi Y, He B, He LX, Liu YN, Qu JM. Cao B, et al. Clin Respir J. 2018 Apr;12(4):1320-1360. doi: 10.1111/crj.12674. Epub 2017 Sep 26. Clin Respir J. 2018. PMID: 28756639 Free PMC article. Review.
Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens.
Song JH, Oh WS, Kang CI, Chung DR, Peck KR, Ko KS, Yeom JS, Kim CK, Kim SW, Chang HH, Kim YS, Jung SI, Tong Z, Wang Q, Huang SG, Liu JW, Lalitha MK, Tan BH, Van PH, Carlos CC, So T; Asian Network for Surveillance of Resistant Pathogens Study Group. Song JH, et al. Int J Antimicrob Agents. 2008 Feb;31(2):107-14. doi: 10.1016/j.ijantimicag.2007.09.014. Epub 2007 Dec 26. Int J Antimicrob Agents. 2008. PMID: 18162378 Free PMC article.
Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia: A Secondary Analysis of a Randomized Clinical Trial.
Dinh A, Duran C, Ropers J, Bouchand F, Davido B, Deconinck L, Matt M, Senard O, Lagrange A, Mellon G, Calin R, Makhloufi S, de Lastours V, Mathieu E, Kahn JE, Rouveix E, Grenet J, Dumoulin J, Chinet T, Pépin M, Delcey V, Diamantis S, Benhamou D, Vitrat V, Dombret MC, Guillemot D, Renaud B, Claessens YE, Labarère J, Aegerter P, Bedos JP, Crémieux AC; Pneumonia Short Treatment (PTC) Study Group. Dinh A, et al. JAMA Netw Open. 2021 Oct 1;4(10):e2129566. doi: 10.1001/jamanetworkopen.2021.29566. JAMA Netw Open. 2021. PMID: 34652445 Free PMC article. Clinical Trial.

Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia - PubMed (original) (raw)